Cadila Healthcare informs about press release

17 Aug 2017 Evaluate

Cadila Healthcare has informed about a press release titled ‘Zydus receives final approval from the USFDA for Telmisartan and Hydrochlorothiazide Tablets’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

917.20 3.30 (0.36%)
17-Dec-2025 11:27 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1775.00
Dr. Reddys Lab 1276.70
Cipla 1494.10
Zydus Lifesciences 917.20
Lupin 2114.05
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×